Authors

• Joshua Richman (ORCID: https://orcid.org/0000-0002-6166-7488)
• Chen Dai
• Debra L. Friedman (ORCID: https://orcid.org/0000-0002-0589-4176)
• Wei Shen (ORCID: https://orcid.org/0000-0003-4838-4923)
• Aman Wadhwa (ORCID: https://orcid.org/0000-0002-3245-2218)
• Sharon M. Castellino (ORCID: https://orcid.org/0000-0001-8367-2002)
• Smita Bhatia (ORCID: https://orcid.org/0000-0002-7755-5683)
• Sandra Kessel
• Justine M. Kahn (ORCID: https://orcid.org/0000-0003-3330-6754)
• Kara M. Kelly (ORCID: https://orcid.org/0000-0003-1473-3937)

Institutions

• Roswell Park Comprehensive Cancer Center (US)
• Emory University (US)
• National Committee for Quality Assurance (US)
• Johnson & Wales University (US)
• Vanderbilt University (US)
• Columbia University Irving Medical Center (US)
• University of Alabama at Birmingham (US)
• New York Oncology Hematology (US)
• Children's Healthcare of Atlanta (US)
• Resonance Research (United States) (US)
• Columbia University (US)
• Vanderbilt University Medical Center (US)

Publication Details

Journal

Cancer Epidemiology Biomarkers & Prevention

Published

2025-01-16

DOI

https://doi.org/10.1158/1055-9965.epi-24-1231

Primary Topic

Acute Lymphoblastic Leukemia research

Type

article

Field-Weighted Citation Impact

0.00